Content Type: Research Publications

Impact of Priority Review Voucher Eligibility on Research and Development of Medical Countermeasures

March 6, 2026

Clinical Benefit and Revenues of Drugs Affected By Rare Pediatric Disease Priority Review Vouchers, 2017-2023

March 6, 2026

Association Between Changes in Prices and Out‐of‐Pocket Costs for Brand‐Name Clinician‐Administered Drugs

March 6, 2026

Price and Variability in Hospital Charges for Generic Indomethacin Suppositories

March 6, 2026

Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications

March 6, 2026

The RACE Act and Pediatric Trials of Adult Cancer Drugs

March 6, 2026

Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration from 1995 to 2014

March 6, 2026

Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention

March 6, 2026

Vaccine Messaging By the FDA: A National Randomized Survey Study

March 6, 2026

Shortages of Essential Generic Drugs with Limited Competition

March 6, 2026

Estimated Savings Under the Medicare High-Value Drug List Model

March 6, 2026

Comparing Supplemental Indications for Cancer Drugs Approved in the US and EU

March 6, 2026